Search

Search Constraints

You searched for: Author/Creator Ajayi, Temitayo

Search Results

2. Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration. Issue 2 (30th November 2020)

3. Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study. (August 2018)

4. Dysphagia and shortness-of-breath as markers for treatment failure and survival in oropharyngeal cancer after radiation. (March 2023)

5. Neurofilament light is a treatment‐responsive biomarker in CLN2 disease. Issue 12 (8th December 2019)

6. Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial. Issue 9 (September 2022)

7. Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: A partially observed Markov decision process model. Issue 4 (14th November 2019)

8. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy. Issue 11 (12th February 2019)